Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Intesity Therapeutics Inc
INTS
Healthcare
Biotechnology
Intensity Therapeutics, Inc., a late-stage clinical biotechnology company, engages in the provision of treatment for the regional and systemic nature of cancer in the United States. Its lead product candidate includes INT230-6, which is in Phase 3 clinical studies for the treatment of soft tissue sarcoma; and neoadjuvant and metastatic triple negative breast cancer which is in Phase 2 clinical...
trials. The company was incorporated in 2012 and is headquartered in Shelton, Connecticut.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (NDAQ:INTS)
New Post
View:
Posts & Comments
Threaded Posts
(0)
•••
PressRelease
X
Post by
PressRelease
on Nov 06, 2025 4:02pm
New Press Release - Intensity Therapeutics Reports Third Quarter 2025 Financial Results and Provides Corporate Update
The Company expects to file a protocol amendment in the INVINCIBLE-4 Study to revise the dosing regimen for the INT230-6 treatment cohort, and to reinitiate patient enrollment in the first quarter of 2026IT-01 Study manuscript published, featuring a comprehensive evaluation of data, including...
read article.
(1441)
•••
Iseneschal
X
Comment by
Iseneschal
on Oct 31, 2025 11:16am
RE:RE:INTS....ur all being led to the Slaughter house
Just keep "averaging down".......u might get lucky and catch the bottom.....Maybe ; ) Now trading at 74 f'king cents....what a game!
(1441)
•••
Iseneschal
X
Comment by
Iseneschal
on Oct 31, 2025 8:14am
RE:INTS....ur all being led to the Slaughter house
Worth a repeat ?? Now trading at $0.98 on 50.5 million shares It's going to get worse....drink some more Kool-Aide ; )
(0)
•••
PressRelease
X
Post by
PressRelease
on Oct 31, 2025 8:00am
New Press Release - Intensity Therapeutics, Inc. Announces Pricing of $4 Million Registered Direct Offering of Common Stock
SHELTON, Conn., Oct. 31, 2025 /PRNewswire/ -- Intensity Therapeutics, Inc. (Nasdaq: INTS) ("Intensity" or the "Company"), a late-stage clinical biotechnology company focused on the discovery and development of novel intratumoral cancer therapies that are designed to kill tumors and increase...
read article.
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 30, 2025 2:30pm
INTS....next support at $0.81
$1.01 now
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 30, 2025 2:26pm
INTS ....back from halt and in total PB mode
$1.09 now
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 30, 2025 2:23pm
INTS....ur all being led to the Slaughter house
$1.24 right now
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 30, 2025 2:16pm
INTS....don't Drink the Kool-Aide
You'll be sorry !!!!!!
(1441)
•••
Iseneschal
X
Post by
Iseneschal
on Oct 30, 2025 2:14pm
INTS....Halted ...but hang on a minute!!!!
This a RS candidate....it was voted on last meeting....here ....read this and u be the judge: https://www.sec.gov/Archives/edgar/data/1567264/000156726425000096/intensity-20251022.htm
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 5:47am
INTS: Intensity Therapeutics Poised for Breakthrough in Canc
https://beyondspx.com/2024/08/02/ints-intensity-therapeutics-poised-for-breakthrough-in-cancer-treatment/
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
ACL Construction identified as the preferred proponent for a highway project on the Alaska Highway
A junior mining company focused on revitalizing North America's tungsten supply
A first-mover position in Argentina’s newly opened Mendoza copper exploration district
Spanish Mountain Gold Announces Sale of a 1.5% Royalty to Wheaton Precious Metals for US$55 Million
Grizzly Sampling & Fieldwork Results in Three New Gold-Copper-Silver Discoveries at BC Critical Minerals & Precious Metals Project
Kraig Biocraft Advances Record Production of 1.8 Metric Tons of Recombinant Spider Silk Cocoons
Podcasts